Search Results - "Feldman, Reid"
-
1
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection
Published in Cancer research (Chicago, Ill.) (01-07-2016)“…ICOS is a T-cell coregulatory receptor that provides a costimulatory signal to T cells during antigen-mediated activation. Antitumor immunity can be improved…”
Get full text
Journal Article -
2
Abstract 2328: ICOS signaling promotes CD4+ effector T-cell function during antitumor responses
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Inducible costimulator (ICOS) is a CD28-related cell surface receptor which provides an important costimulatory signal to T cells during activation. Prior work…”
Get full text
Journal Article -
3
Black Holes and Boilerplate in M&A Practice
Published in Business law international (01-05-2018)“…The study used a computer-assisted 'vector-space' method to analyse sets of deal terms (including selected reps, covenants, closing conditions and financial…”
Get full text
Journal Article -
4
Recent Trends in European SPAs and Comparisons with US Practice
Published in Business law international (01-09-2016)“…[...]unnecessary confusion and complexity can be avoided by choosing the law of one of those countries. The SPA commonly used generally includes the following…”
Get full text
Journal Article -
5
Abstract 4598: Triggering of OX40 on T cells by a novel monoclonal antibody elicits robust antitumor immunity<!–EndFragment–>
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…T cell costimulation is an attractive strategy for cancer treatment in addition to check point inhibitors. Costimulatory molecule OX40 is a member of the TNF…”
Get full text
Journal Article -
6
Targeting OX40 by monoclonal antibody PF-04518600 to enhance T cell functions and inhibit tumor growth
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
7
Abstract LB-194: Targeting tumor associated myeloid cells with CCR2 inhibitor PF-04136309 enhances gemcitabine/paclitaxel and doxorubicin anti-tumor activity
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Purpose: MDSCs and macrophages have been reported to be increased in the tumor microenvironment by chemotherapy treatment. These cells may limit the beneficial…”
Get full text
Journal Article -
8
Life is degrading. SCF ubiquitin ligases: Their components and functions
Published 01-01-2000“…The cell cycle is defined by a series of phases demarcated by orgasms at different levels (or biochemically imposed transitions). In the budding yeast S…”
Get full text
Dissertation